Adamis Pharmaceuticals Corp (ADMP): R/S = Strong pipeline generating sales

Reply Private New

Next 10 Prev Next

Send PM

Followers	15
Posts	2814
Boards Moderated	1
Alias Born	06/04/2020

FREE
ADMP REPORT

ShortsRClowns

Re: None

Monday, 07/25/2022 3:38:07 PM

Monday, July 25, 2022 3:38:07 PM

R/S = Strong pipeline generating sales

Rolling Stones are old and they suck!

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADMP News

Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 03/17/2023 12:09:24 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/17/2023 12:07:50 PM
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/16/2023 08:24:01 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/16/2023 07:59:02 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/14/2023 09:26:36 PM
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 03/14/2023 08:01:00 PM
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/14/2023 12:30:00 PM
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger • GlobeNewswire Inc. • 02/27/2023 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 12:09:13 PM
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements • GlobeNewswire Inc. • 02/22/2023 09:01:00 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM

More ADMP News

InvestorsHub NewsWire

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards:

Quotes:

Stock Options

Detailed Quote

Recent ADMP News

More ADMP News